Illumina Body Map 2: averaged replicates
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HNF4A | hg19_v2_chr20_+_42984330_42984445 | 0.83 | 2.9e-09 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_+_96698406 Show fit | 28.68 |
ENST00000260682.6
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
|
chr17_+_4675175 Show fit | 24.03 |
ENST00000270560.3
|
transmembrane 4 L six family member 5 |
|
chr10_+_96522361 Show fit | 23.86 |
ENST00000371321.3
|
cytochrome P450, family 2, subfamily C, polypeptide 19 |
|
chr10_-_96829246 Show fit | 23.72 |
ENST00000371270.3
ENST00000535898.1 ENST00000539050.1 |
cytochrome P450, family 2, subfamily C, polypeptide 8 |
|
chr10_-_129691195 Show fit | 23.41 |
ENST00000368671.3
|
clarin 3 |
|
chr5_-_35048047 Show fit | 21.66 |
ENST00000231420.6
|
alanine--glyoxylate aminotransferase 2 |
|
chr6_+_30130969 Show fit | 21.22 |
ENST00000376694.4
|
tripartite motif containing 15 |
|
chr3_-_42917363 Show fit | 20.50 |
ENST00000437102.1
|
cytochrome P450, family 8, subfamily B, polypeptide 1 |
|
chr20_+_56136136 Show fit | 20.39 |
ENST00000319441.4
ENST00000543666.1 |
phosphoenolpyruvate carboxykinase 1 (soluble) |
|
chr11_-_116694009 Show fit | 20.31 |
ENST00000357780.3
|
apolipoprotein A-IV |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.0 | 62.9 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
10.6 | 52.9 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) positive regulation of phospholipid catabolic process(GO:0060697) |
2.3 | 51.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
2.4 | 42.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
5.2 | 41.3 | GO:0034371 | chylomicron remodeling(GO:0034371) |
1.7 | 37.7 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
8.7 | 34.7 | GO:0035565 | regulation of pronephros size(GO:0035565) |
0.8 | 32.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 32.1 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
3.8 | 30.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 227.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 74.5 | GO:0070062 | extracellular exosome(GO:0070062) |
8.2 | 73.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.2 | 56.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.7 | 55.9 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 46.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
3.8 | 37.7 | GO:0005579 | membrane attack complex(GO:0005579) |
1.9 | 37.0 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 26.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 26.6 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 75.3 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
7.6 | 52.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
10.5 | 52.4 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
1.7 | 52.2 | GO:0001848 | complement binding(GO:0001848) |
6.4 | 38.2 | GO:0004882 | androgen receptor activity(GO:0004882) |
4.6 | 37.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.9 | 32.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
1.3 | 30.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
5.0 | 30.0 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
2.8 | 28.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 124.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.6 | 59.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 53.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 32.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 15.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 5.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 5.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 4.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 3.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 3.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.2 | 129.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
3.0 | 90.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 59.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.2 | 50.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
1.7 | 45.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
1.2 | 37.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.3 | 34.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.1 | 27.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.1 | 22.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.2 | 21.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |